Dow Up 1.41% Nasdaq Up 1.46%

Cytokinetics, Incorporated (CYTK)

-NasdaqCM
3.41 Up 0.08(2.40%) 10:29AM EDT - Nasdaq Real Time Price
Prev Close:3.33
Open:3.37
Bid:3.34 x 600
Ask:3.38 x 2300
1y Target Est:10.80
Beta:1.3
Next Earnings Date:30-Oct-14CYTK Earnings announcement
Day's Range:3.31 - 3.41
52wk Range:3.05 - 13.26
Volume:14,760
Avg Vol (3m):398,645
Market Cap:124.83M
P/E (ttm):N/A
EPS (ttm):-0.72
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
CYTKUp 2.40%124.83M
BIIBUp 1.63%74.18B
LGNDUp 3.47%1.09B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):2.73
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.99
Quarterly EPS Est (Sep-14) :-0.24
Mean Recommendation*:2.4
PEG Ratio (5 yr expected):-0.22

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Cytokinetics, Incorporated, a clinical stage biopharmaceutical company, focuses on the discovery and development of novel small molecule therapeutics that modulate muscle function for the potential treatment of serious diseases and medical conditi... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback